Pharmacy
Hello, Mary O'connor
Manage E-mail  |  Logout

Article ID

Home
General Pharmacy
Messages (0)
Conferences
Jobs
Newsletters
My Library
Topics in
Pharmacy
        Adverse Drug Reactions
        Antimicrobials
        Basic Science
        Cardiac/Hypertension
        Chemotherapy/Oncology
        Complementary Medicine
        Dosing
        Drug Approvals
        Drug Interactions
        Drug Resistance
        Drug Trials
        Drug/Product Alerts
        Economics of Medicine
        Major Studies
        Neuro/Psych pharmacology
        Other Drugs
        Over The Counter (OTC)
        Pain Management
        Patient Counseling
        Pharmacoeconomics
        Pharmacokinetics
        Pharmacy Management
        Popular Press
        Stomach/GI
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
 
Sponsor

Articles: Stomach/GI



Latest (1) Month's Top Read  
Receive free subspecialty "5-minute updates" via email

Prior Articles


Selecting appropriate anti-TNF agents in inflammatory bowel disease
Expert Review of Gastroenterology & Hepatology, 06/16/09
Sponsor
Effect of SLCO1B1 polymorphism on the plasma concentrations of bile acids and bile acid synthesis marker in humans
Pharmacogenetics and genomics, 06/15/09
Chemosensory perception and medicinal plants for digestive ailments in a Mapuche community in NW Patagonia, Argentina
Journal of Ethnopharmacology, 06/15/09
Anti-Helicobacter pylori therapy followed by celecoxib on progression of gastric precancerous lesions
World Journal of Gastroenterology, 06/15/09    Free full text
A dose-up of ursodeoxycholic acid decreases transaminases in hepatitis C patients
World Journal of Gastroenterology, 06/15/09    Free full text
New perspectives in the treatment of advanced or metastatic gastric cancer
World Journal of Gastroenterology, 06/15/09    Free full text
Significant Differences Between Crohn's Disease and Ulcerative Colitis Regarding the Impact of Body Mass Index and Initial Disease Activity on Responsiveness to Azathioprine
Digestive Diseases and Sciences, 06/15/09
Involvement of Human Organic Cation Transporter 1 (OCT1) in the Hepatic Uptake of YM155 Monobromide, 1-(2-Methoxyethyl)-2-methyl-4,9-dioxo-3-(pyrazin-2-ylmethyl)-4,9-dihydro-1H-naphtho[2,3-d]imidazolium Bromide, a Novel, Small Molecule Survivin Suppressant
Drug Metabolism and Disposition, 06/12/09
Methadone Induces the Expression of Hepatic Drug-Metabolizing Enzymes Through the Activation of Pregnane X Receptor and Constitutive Androstane Receptor
Drug Metabolism and Disposition, 06/12/09
Hepatic CYP3A suppression by high concentrations of proteasomal inhibitors: A consequence of endoplasmic reticulum (ER)-stress induction, activation of PERK and GCN2 eIF2 alpha kinases and global translational shut-off
Molecular Pharmacology, 06/12/09
Refractory Colitis Following Anti-CTLA4 Antibody Therapy: Analysis of Mucosal FOXP3+ T Cells
Digestive Diseases and Sciences, 06/11/09
Phase III Trial Started to Evaluate Combination Therapy of Nexavar and Tarceva in Patients with Liver Cancer
BayNews International, 06/11/09    Free full text
The Binding Specificity and Selective Antagonism of Vedolizumab, an Anti-alpha 4 beta 7 Integrin Therapeutic Antibody in Development for Inflammatory Bowel Diseases
Journal of Pharmacology and Experimental Therapeutics, 06/10/09
Sustained Response of Hepatitis B e Antigen-Negative Patients 3 Years After Treatment with Peginterferon Alfa-2a
Gastroenterology, 06/10/09
Budesonide Is Effective in Treating Lymphocytic Colitis: A Randomized Double-Blind Placebo-Controlled Study
Gastroenterology, 06/10/09
Efficacy of L-Ornithine L-Aspartate in Acute Liver Failure: A Double-Blind, Randomized, Placebo-Controlled Study
Gastroenterology, 06/10/09
Cytochrome P450 2C9 Variants Influence Response to Celecoxib for Prevention of Colorectal Adenoma
Gastroenterology, 06/10/09
Mycophenolate mofetil as rescue treatment for autoimmune liver disease in children: A 5-year follow-up
Journal of Hepatology, 06/10/09
Evaluation of VCH-759 monotherapy in hepatitis C infection
Journal of Hepatology, 06/10/09
Positive and negative prediction of sustained virologic response at weeks 2 and 4 of treatment with albinterferon alfa-2b or peginterferon alfa-2a in treatment-naive patients with genotype 1, chronic hepatitis C
Journal of Hepatology, 06/10/09

Receive free subspecialty "5-minute updates" via email
Indexed Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist more...
250 Available Pages
First    Prev    14      15      16      17      18      19      20      21      22      23      Next      Last
Sponsor

Read a Different Specialty

Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pain
Pediatrics
Practice Management
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Pharmacy Articles Profession Index

Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2009 MDLinx, Inc.